India eyes global pharma dominance with a ₹5,000 crore revitalisation plan
The initiative, part of the Promotion of Research & Innovation in Pharma MedTech Sector (PRIP) scheme—launched in August 2023 for a five-year period—seeks to boost domestic R&D and reduce India’s reliance on imported technology. Also read: DCGI seeks post-market surveillance data on 2 combination drugs within 3 months “We are planning to float the expression … Read more